These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17276971)

  • 1. Reward deficiency syndrome in obesity: a preliminary cross-sectional trial with a Genotrim variant.
    Blum K; Chen TJ; Meshkin B; Downs BW; Gordon CA; Blum S; Mengucci JF; Braverman ER; Arcuri V; Varshavskiy M; Deutsch R; Martinez-Pons M
    Adv Ther; 2006; 23(6):1040-51. PubMed ID: 17276971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotrim, a DNA-customized nutrigenomic product, targets genetic factors of obesity: hypothesizing a dopamine-glucose correlation demonstrating reward deficiency syndrome (RDS).
    Blum K; Chen TJ; Meshkin B; Downs BW; Gordon CA; Blum S; Mangucci JF; Braverman ER; Arcuri V; Deutsch R; Pons MM
    Med Hypotheses; 2007; 68(4):844-52. PubMed ID: 17071010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: a hypothesis.
    Blum K; Chen TJ; Meshkin B; Waite RL; Downs BW; Blum SH; Mengucci JF; Arcuri V; Braverman ER; Palomo T
    Med Hypotheses; 2007; 69(5):1054-60. PubMed ID: 17467918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LG839: anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome.
    Blum K; Chen AL; Chen TJ; Rhoades P; Prihoda TJ; Downs BW; Waite RL; Williams L; Braverman ER; Braverman D; Arcuri V; Kerner M; Blum SH; Palomo T
    Adv Ther; 2008 Sep; 25(9):894-913. PubMed ID: 18781289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine and glucose, obesity, and reward deficiency syndrome.
    Blum K; Thanos PK; Gold MS
    Front Psychol; 2014; 5():919. PubMed ID: 25278909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced reward-driven eating accounts for the impact of a mindfulness-based diet and exercise intervention on weight loss: Data from the SHINE randomized controlled trial.
    Mason AE; Epel ES; Aschbacher K; Lustig RH; Acree M; Kristeller J; Cohn M; Dallman M; Moran PJ; Bacchetti P; Laraia B; Hecht FM; Daubenmier J
    Appetite; 2016 May; 100():86-93. PubMed ID: 26867697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reward deficiency syndrome: genetic aspects of behavioral disorders.
    Comings DE; Blum K
    Prog Brain Res; 2000; 126():325-41. PubMed ID: 11105655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivitamin and dietary supplements, body weight and appetite: results from a cross-sectional and a randomised double-blind placebo-controlled study.
    Major GC; Doucet E; Jacqmain M; St-Onge M; Bouchard C; Tremblay A
    Br J Nutr; 2008 May; 99(5):1157-67. PubMed ID: 17977472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does dopaminergic reward system contribute to explaining comorbidity obesity and ADHD?
    Liu LL; Li BM; Yang J; Wang YW
    Med Hypotheses; 2008; 70(6):1118-20. PubMed ID: 18158220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors.
    Blum K; Braverman ER; Holder JM; Lubar JF; Monastra VJ; Miller D; Lubar JO; Chen TJ; Comings DE
    J Psychoactive Drugs; 2000 Nov; 32 Suppl():i-iv, 1-112. PubMed ID: 11280926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuro-Genetics of Reward Deficiency Syndrome (RDS) as the Root Cause of "Addiction Transfer": A New Phenomenon Common after Bariatric Surgery.
    Blum K; Bailey J; Gonzalez AM; Oscar-Berman M; Liu Y; Giordano J; Braverman E; Gold M
    J Genet Syndr Gene Ther; 2011 Dec; 2012(1):. PubMed ID: 23483116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine for "wanting" and opioids for "liking": a comparison of obese adults with and without binge eating.
    Davis CA; Levitan RD; Reid C; Carter JC; Kaplan AS; Patte KA; King N; Curtis C; Kennedy JL
    Obesity (Silver Spring); 2009 Jun; 17(6):1220-5. PubMed ID: 19282821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports.
    Miller DK; Bowirrat A; Manka M; Miller M; Stokes S; Manka D; Allen C; Gant C; Downs BW; Smolen A; Stevens E; Yeldandi S; Blum K
    Postgrad Med; 2010 Nov; 122(6):188-213. PubMed ID: 21084795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary Protein Modifies the Effect of the
    Huang T; Zheng Y; Hruby A; Williamson DA; Bray GA; Shen Y; Sacks FM; Qi L
    J Nutr; 2017 Mar; 147(3):439-444. PubMed ID: 28148682
    [No Abstract]   [Full Text] [Related]  

  • 15. Reward circuitry dopaminergic activation regulates food and drug craving behavior.
    Blum K; Liu Y; Shriner R; Gold MS
    Curr Pharm Des; 2011; 17(12):1158-67. PubMed ID: 21492092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk Testing.
    Blum K; Baron D; Lott L; Ponce JV; Siwicki D; Boyett B; Steinberg B; Modestino EJ; Fried L; Hauser M; Simpatico T; Downs BW; McLaughlin T; Hajela R; Badgaiyan RD
    Curr Psychopharmacol; 2020; 9(1):7-21. PubMed ID: 32432025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are dopaminergic genotypes risk factors for eating behavior and obesity in adults?
    Avsar O; Kuskucu A; Sancak S; Genc E
    Neurosci Lett; 2017 Jul; 654():28-32. PubMed ID: 28629779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
    Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothesizing Nutrigenomic-Based Precision Anti-Obesity Treatment and Prophylaxis: Should We Be Targeting Sarcopenia Induced Brain Dysfunction?
    Blum K; Gold MS; Llanos-Gomez L; Jalali R; Thanos PK; Bowirrat A; Downs WB; Bagchi D; Braverman ER; Baron D; Roy AK; Badgaiyan RD
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574696
    [No Abstract]   [Full Text] [Related]  

  • 20. Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS).
    Blum K; Chen TJ; Chen AL; Madigan M; Downs BW; Waite RL; Braverman ER; Kerner M; Bowirrat A; Giordano J; Henshaw H; Gold MS
    Med Hypotheses; 2010 Mar; 74(3):513-20. PubMed ID: 19914781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.